Transgene SA (TNG.PA)
EUR 0.6
(-1.63%)
EUR 0.6
(-1.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.22 EUR | 33.33% |
| 2022 | -0.33 EUR | -50.0% |
| 2021 | -0.22 EUR | 0.0% |
| 2020 | -0.22 EUR | 15.38% |
| 2019 | -0.26 EUR | -300.0% |
| 2018 | 0.13 EUR | 125.49% |
| 2017 | -0.51 EUR | -13.33% |
| 2016 | -0.45 EUR | 62.5% |
| 2015 | -1.20 EUR | 4.76% |
| 2014 | -1.26 EUR | 5.97% |
| 2013 | -1.34 EUR | 1.47% |
| 2012 | -1.36 EUR | -1.49% |
| 2011 | -1.34 EUR | -11.67% |
| 2010 | -1.20 EUR | 0.83% |
| 2009 | -1.21 EUR | -53.16% |
| 2008 | -0.79 EUR | -192.59% |
| 2007 | -0.27 EUR | 80.15% |
| 2006 | -1.36 EUR | 0.0% |
| 2004 | -1.97 EUR | 1.5% |
| 2003 | -2.00 EUR | -12.99% |
| 2002 | -1.77 EUR | 29.76% |
| 2001 | -2.52 EUR | 32.98% |
| 2000 | -3.76 EUR | -21.29% |
| 1999 | -3.10 EUR | 53.1% |
| 1998 | -6.61 EUR | -95.56% |
| 1997 | -3.38 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.16 EUR | 0.0% |
| 2023 Q1 | -0.08 EUR | 55.56% |
| 2023 Q4 | -0.03 EUR | 0.0% |
| 2023 Q3 | -0.03 EUR | 80.19% |
| 2023 Q2 | -0.16 EUR | -100.0% |
| 2023 FY | - EUR | 33.33% |
| 2022 Q2 | -0.15 EUR | -94.05% |
| 2022 Q1 | -0.08 EUR | 2.52% |
| 2022 Q4 | -0.18 EUR | -100.22% |
| 2022 FY | - EUR | -50.0% |
| 2022 Q3 | -0.09 EUR | 40.07% |
| 2021 Q3 | -0.04 EUR | 71.79% |
| 2021 FY | - EUR | 0.0% |
| 2021 Q2 | -0.14 EUR | -100.0% |
| 2021 Q4 | -0.08 EUR | -100.76% |
| 2021 Q1 | -0.07 EUR | 61.11% |
| 2020 Q1 | -0.02 EUR | 64.03% |
| 2020 Q4 | -0.18 EUR | -92.51% |
| 2020 Q3 | -0.09 EUR | -252.83% |
| 2020 Q2 | -0.03 EUR | -76.67% |
| 2020 FY | - EUR | 15.38% |
| 2019 Q4 | -0.04 EUR | -143.86% |
| 2019 Q3 | -0.02 EUR | 93.16% |
| 2019 FY | - EUR | -300.0% |
| 2019 Q1 | -0.12 EUR | -163.16% |
| 2019 Q2 | -0.25 EUR | -108.33% |
| 2018 FY | - EUR | 125.49% |
| 2018 Q1 | -0.12 EUR | -20.0% |
| 2018 Q2 | -0.12 EUR | 0.0% |
| 2018 Q4 | 0.19 EUR | 0.0% |
| 2018 Q3 | 0.19 EUR | 258.33% |
| 2017 Q3 | -0.10 EUR | 41.18% |
| 2017 Q1 | -0.17 EUR | -101.42% |
| 2017 Q2 | -0.17 EUR | 0.0% |
| 2017 FY | - EUR | -13.33% |
| 2017 Q4 | -0.10 EUR | 0.0% |
| 2016 Q2 | -0.15 EUR | 0.0% |
| 2016 Q1 | -0.15 EUR | 28.57% |
| 2016 Q3 | -0.08 EUR | 43.73% |
| 2016 FY | - EUR | 62.5% |
| 2016 Q4 | -0.08 EUR | 0.0% |
| 2015 Q3 | -0.21 EUR | 25.0% |
| 2015 Q2 | -0.28 EUR | 0.0% |
| 2015 Q4 | -0.21 EUR | 0.0% |
| 2015 FY | - EUR | 4.76% |
| 2015 Q1 | -0.28 EUR | -7.69% |
| 2014 FY | - EUR | 5.97% |
| 2014 Q4 | -0.26 EUR | 0.0% |
| 2014 Q3 | -0.26 EUR | 3.7% |
| 2014 Q2 | -0.27 EUR | 0.0% |
| 2014 Q1 | -0.27 EUR | 12.9% |
| 2013 Q2 | -0.37 EUR | 0.0% |
| 2013 FY | - EUR | 1.47% |
| 2013 Q4 | -0.31 EUR | 0.0% |
| 2013 Q1 | -0.37 EUR | -8.82% |
| 2013 Q3 | -0.31 EUR | 16.22% |
| 2012 Q4 | -0.34 EUR | 0.0% |
| 2012 Q3 | -0.34 EUR | 0.0% |
| 2012 FY | - EUR | -1.49% |
| 2011 FY | - EUR | -11.67% |
| 2010 FY | - EUR | 0.83% |
| 2009 FY | - EUR | -53.16% |
| 2008 FY | - EUR | -192.59% |
| 2007 FY | - EUR | 80.15% |
| 2006 FY | - EUR | 0.0% |
| 2005 Q2 | -0.45 EUR | -7.14% |
| 2005 Q1 | -0.42 EUR | -7.69% |
| 2004 Q2 | -0.51 EUR | 1.92% |
| 2004 Q1 | -0.52 EUR | 17.46% |
| 2004 Q3 | -0.57 EUR | -11.76% |
| 2004 Q4 | -0.39 EUR | 31.58% |
| 2004 FY | - EUR | 1.5% |
| 2003 FY | - EUR | -12.99% |
| 2003 Q4 | -0.63 EUR | -50.0% |
| 2003 Q2 | -0.49 EUR | -6.52% |
| 2003 Q3 | -0.42 EUR | 14.29% |
| 2003 Q1 | -0.46 EUR | -4.55% |
| 2002 Q4 | -0.44 EUR | -10.0% |
| 2002 FY | - EUR | 29.76% |
| 2002 Q1 | -0.46 EUR | 25.81% |
| 2002 Q2 | -0.46 EUR | 0.0% |
| 2002 Q3 | -0.40 EUR | 13.04% |
| 2001 Q3 | -0.42 EUR | 40.85% |
| 2001 Q1 | -0.91 EUR | -22.97% |
| 2001 FY | - EUR | 32.98% |
| 2001 Q4 | -0.62 EUR | -47.62% |
| 2001 Q2 | -0.71 EUR | 21.98% |
| 2000 Q2 | -0.65 EUR | 41.44% |
| 2000 Q4 | -0.74 EUR | 41.27% |
| 2000 FY | - EUR | -21.29% |
| 2000 Q3 | -1.26 EUR | -93.85% |
| 2000 Q1 | -1.11 EUR | -20.65% |
| 1999 Q3 | -0.79 EUR | 0.0% |
| 1999 FY | - EUR | 53.1% |
| 1999 Q4 | -0.92 EUR | -16.46% |
| 1999 Q1 | -0.62 EUR | 53.38% |
| 1999 Q2 | -0.79 EUR | -27.42% |
| 1998 FY | - EUR | -95.56% |
| 1998 Q1 | -3.70 EUR | 0.0% |
| 1998 Q2 | -0.96 EUR | 74.05% |
| 1998 Q3 | -0.92 EUR | 4.17% |
| 1998 Q4 | -1.33 EUR | -44.57% |
| 1997 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -83.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 93.586% |
| Adocia SA | -1.91 EUR | 88.482% |
| Aelis Farma SA | -0.39 EUR | 43.59% |
| Biophytis S.A. | -12.55 EUR | 98.247% |
| Advicenne S.A. | -0.67 EUR | 67.164% |
| genOway Société anonyme | 0.17 EUR | 229.412% |
| IntegraGen SA | -0.03 EUR | -749.421% |
| Medesis Pharma S.A. | -0.80 EUR | 72.5% |
| Neovacs S.A. | -0.00 EUR | -8700.0% |
| NFL Biosciences SA | -0.46 EUR | 52.174% |
| Plant Advanced Technologies SA | 0.07 EUR | 414.286% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -141.758% |
| Sensorion SA | -0.17 EUR | -29.412% |
| Theranexus Société Anonyme | -0.88 EUR | 75.0% |
| TME Pharma N.V. | -1.34 EUR | 83.582% |
| Valbiotis SA | -0.59 EUR | 62.712% |
| TheraVet SA | -0.49 EUR | 55.102% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -46.667% |
| DBV Technologies S.A. | -0.71 EUR | 69.014% |
| Genfit S.A. | -0.58 EUR | 62.069% |
| GeNeuro SA | -0.59 EUR | 62.712% |
| Innate Pharma S.A. | -0.09 EUR | -133.794% |
| Inventiva S.A. | -2.43 EUR | 90.947% |
| MaaT Pharma SA | -1.73 EUR | 87.283% |
| MedinCell S.A. | -0.88 EUR | 75.0% |
| Nanobiotix S.A. | -1.08 EUR | 79.63% |
| OSE Immunotherapeutics SA | -1.18 EUR | 81.356% |
| Poxel S.A. | -0.91 EUR | 75.824% |
| GenSight Biologics S.A. | -0.54 EUR | 59.259% |
| Valneva SE | -0.73 EUR | 69.863% |